10-30611983-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_183058.3(LYZL2):āc.419A>Gā(p.Asp140Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000547 in 1,461,882 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_183058.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LYZL2 | NM_183058.3 | c.419A>G | p.Asp140Gly | missense_variant | 5/5 | ENST00000647634.2 | NP_898881.3 | |
LYZL2 | XM_011519306.3 | c.478A>G | p.Thr160Ala | missense_variant | 4/4 | XP_011517608.1 | ||
LYZL2 | XR_930469.3 | n.485-4448A>G | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LYZL2 | ENST00000647634.2 | c.419A>G | p.Asp140Gly | missense_variant | 5/5 | NM_183058.3 | ENSP00000497408.1 | |||
LYZL2 | ENST00000375318.4 | c.557A>G | p.Asp186Gly | missense_variant | 5/5 | 1 | ENSP00000364467.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000547 AC: 8AN: 1461882Hom.: 0 Cov.: 31 AF XY: 0.00000550 AC XY: 4AN XY: 727242
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 18, 2021 | The c.557A>G (p.D186G) alteration is located in exon 5 (coding exon 5) of the LYZL2 gene. This alteration results from a A to G substitution at nucleotide position 557, causing the aspartic acid (D) at amino acid position 186 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at